Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04382040 |
|---|---|
| Brief Title: | A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 |
| First Submitted : | May 7, 2020 |
| First Submitted that Met QC Criteria : | May 7, 2020 |
| First Posted : | May 11, 2020 |
| Last Update Submitted that Met QC Criteria : | March 2, 2021 |
| Last Update Posted : | March 3, 2021 |